prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumB, PATIENT HISTORY: CHIEF COMPLAINT/ PRE-OP/ POST-OP DIAGNOSIS Left breast invasive ductal carcinoma. LMP DATE Not applicable. PROCEDURE Left segmental mastectomy with sentinel lymph node blopay. SPECIFIC CLINICAL QUESTION Not listed. OUTSIDE TISSUE DIAGNOSIS Not listed. PRIOR MALIGNANCY. Not listed. CHEMORADIATION THERAPY: Not listed. OTHER DISEASFS Not listed. FINAL DIAGNOSIS: PART 1: LYMPH NODE, NON-SENTINEL, BIOPSY -. ONE (1) LYMPH NODE, NEGATIVE FOR METASTATIC.CARCINOMA1). PART 2: LYMPH NODE, LEFT AXILLA, SENTINEL #1, BIOPSY -. ONE (1) LYMPH NODE. NEGATIVE FOR METASTATIC CARCINOMA (0/1). PART 3: LYMPH NODE, LEFT AXILLA, SENTINEL #2, BIOPSY -. ONE (1) LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA (0/1). PART 4: BREAST, LEFT. SEGMENTAL MASTECTOMY -. A. INVASIVE DUCTAL CARCINOMA, NO SPECIAL TYPE. B. NOTTINGHAM GRADE III (TUBULE FORMATION: 3, NUCLEAR PLEOMORPHISM: 3, MITOTIC ACTIVITY: 3;. TOTAL SCORE: 9/9). c. THE INVASIVE TUMOR MEASURES 2.6 CM IN LARGEST DIMENSION. D. DUCTAL CARCINOMA IN SITU, NUCLEAR GRADE 3, SOLID TYPE WITH COMEDO NECROSIS. E. THE DUCTAL CARCINOMA IN SITU CONSTITUTES 40% OF THE TOTAL TUMOR VOLUME ANO IS PRESENT. ADMIXED WITH THE INVASIVE COMPONENT. F. NO LYMPHOVASCULAR SPACE INVASION is NOTED. G. RESECTION MARGINS ARE NEGATIVE FOR CARCINOMA. H. INVASIVE CARCINOMA IS 0.4 CM FROM THE NEAREST (ANTERIOR) MARGIN. I. DUCTAL CARCINOMA IN SITU IS 0.3 CM FROM THE NEAREST (ANTERIOR) MARGIN. J. ATYPICAL DUCTAL HYPERPLASIA. K. THE NON-NEOPLASTIC BREAST SHOWS DUCTAL EPITHELIAL HYPERPLASIA, INTRADUCTAL PAPILLOMA,. RADIAL SCAR, COLUMNAR CELL CHANGES, AND FIBROCYSTIC CHANGES. L. PREVIOUS BIOPSY SITE CHANGES. PART 5: LYMPH NODE, LEFT "WTRAMAMMARY", EXCISIONAL BIOPSY -. A. ONE/1 LYMPN NODE, NEGATIVE/FOR. B. BENIGN PERINODAL ADIPOSE TISSUE. C. NO OUCTAL BREAST TISSUE SEEN. COMMENT: Part 4: The invasive tumor was reported to be positive for Estrogen Receptora (H-ecore: 250), positive for Progesterone. Receptors (H-score: 75) and also positive for HER2, as per previous pathology report. CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Left. PROCEDURE: Segmental. Clock position. 12. SIZE OF TUMOR: Maximum dimension invasive component: 26 mm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS. NOTTINGHAM SCORE: Nucleer grade: 3. Tubule formation: 3. Mitotic activity score 3. Total Nottingham score: 9. Nottingham grade (1. 2. 3): 3. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: Not applicable. CALCIFICATION: TUMOR TYPE, IN SITU: Solid. Comedo. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Distance of invasive tumor to closest margin: 4 mm. SURG MARGINS INVOLVED BY IN SITU COMPONENT: Distance of in situ disesse to closest margin: 3 mm. LYMPH NODES POSITIVE;. o. LYMPH NODES EXAMINED: 4. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. SENTINEL NODE METASTASIS: NON-NEOPLASTIC BREAST TISSUE: Radial scar, Papilloma, FCD. T STAGE, PATHOLOGIC: pT2. N STAGE MODIFIER: (sn). N STAGE, PATHOLOGIC: pNO. M STAGE: Not applicable. ESTROGEN RECEPTORS: positive, H-score 250. PROGESTERONE RECEPTORS: positive, H-score: 75. HER2/NEU:

expanded version (tokens=1533) : 
 According to the pathology report, the patient was diagnosed with invasive ductal carcinoma - subtype LumB. The lymph node biopsy and sentinel lymph node biopsies were all negative for metastatic carcinoma. The invasive ductal carcinoma was Nottingham Grade III (with scores of 3 for tubule formation, nuclear pleomorphism, and mitotic activity, yielding a total score of 9/9). The tumor measured 2.6 cm in its largest dimension, and there was also ductal carcinoma in situ, nuclear grade 3, solid type with comedo necrosis, which constituted 40% of the total tumor volume and was mixed with the invasive component. No lymphovascular space invasion was noted, and the resection margins were negative for carcinoma. The nearest margin to invasive carcinoma was 0.4 cm, while the nearest margin to ductal carcinoma in situ was 0.3 cm. There was also atypical ductal hyperplasia and other changes in the non-neoplastic breast tissue. The pathology report indicated that the invasive tumor was positive for estrogen receptors (H-score: 250), positive for progesterone receptors (H-score: 75), and also positive for HER2 according to a previous report. The tumor was pT2, and the lymph nodes examined were negative for metastasis. In summary, the patient has LumB subtype invasive ductal carcinoma with ductal carcinoma in situ and atypical ductal hyperplasia. The tumor is high grade

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1681) : 
 The pathology report revealed that the patient with Invasive ductal carcinoma - subtype LumB has no metastatic carcinoma in lymph nodes. The tumor was Nottingham Grade III, with a size of 2.6 cm and ductal carcinoma in situ constituting 40% of the tumor volume. No lymphovascular space invasion was found, and surgical margins were negative for carcinoma. The HER2 was positive with estrogen and progesterone receptors scoring H-score: 250 and 75, respectively.

